Welcome to the UPF Digital Repository

Bipolar disorder and antibodies against the N-methyl-d-aspartate receptor: A gate to the involvement of autoimmunity in the pathophysiology of bipolar illness.

Show simple item record

dc.contributor.author León Caballero, Jordi
dc.contributor.author Pacchiarotti, Isabella
dc.contributor.author Murru, Andrea
dc.contributor.author Valentí, M.
dc.contributor.author Colom, Francesc
dc.contributor.author Benach, B.
dc.contributor.author Pérez Solá, Victor
dc.contributor.author Dalmau, Josep
dc.contributor.author Vieta, Eduard
dc.date.accessioned 2015-11-17T11:16:29Z
dc.date.issued 2015
dc.identifier.citation León-Caballero J, Pacchiarotti I, Murru A, Valentí M, Colom F, Benach B. et al. Bipolar disorder and antibodies against the N-methyl-d-aspartate receptor: A gate to the involvement of autoimmunity in the pathophysiology of bipolar illness. Neurosci Biobehav Rev. 2015 Aug;55:403-12. doi: 10.1016/j.neubiorev.2015.05.012
dc.identifier.issn 0149-7634
dc.identifier.uri http://hdl.handle.net/10230/25110
dc.description.abstract The high prevalence of comorbidity between bipolar disorder (BD) and other medical conditions, including autoimmune diseases, supports the hypothesis of the nature of BD as a biological illness category. Hence, an immune dysregulation process may play an important role in the development of at least certain subtypes of BD. Increasing evidence also suggests that the N-methyl-d-aspartate receptor (NMDAR) may be relevant in the pathophysiology of BD. A possible key mechanism underlying the physiopathology of certain autoimmune diseases that may present with affective symptoms might be the production of anti-NMDAR auto-antibodies (auto-Abs). The best characterized autoimmune anti-NMDAR disease is the anti-NMDAR encephalitis. It has been found that 4% of these patients present isolated, mostly affective, psychiatric manifestations during their illness. An interesting suggestion emerged from this overview is that the same mechanisms that trigger affective symptoms in patients with increased anti-NMDAR auto-Abs levels could be involved in the physiopathology of at least a subgroup of BD. Future studies are needed to characterize the relationship between anti-NMDAR auto-Abs and BD.
dc.description.sponsorship The authors ofthis report wouldlike to acknowledge the support of the Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III (CP08/00140 and PI 12/00910), CIBERSAM (Exp. CB07/ 09/0004), the Spanish Ministry of Education and the Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya to the Bipolar Disorders Group (2014 SGR 398).
dc.format.mimetype application/pdf
dc.language.iso eng
dc.publisher Elsevier
dc.relation.ispartof Neuroscience & Biobehavioral Reviews. 2015 Aug;55:403-12
dc.rights Copyright © 2015 Elsevier Ltd. All rights reserved.
dc.subject.other Psicosi maniacodepressiva
dc.subject.other Autoimmunitat
dc.subject.other Depressió psíquica
dc.title Bipolar disorder and antibodies against the N-methyl-d-aspartate receptor: A gate to the involvement of autoimmunity in the pathophysiology of bipolar illness.
dc.type info:eu-repo/semantics/article
dc.identifier.doi http://dx.doi.org/10.1016/j.neubiorev.2015.05.012
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.type.version info:eu-repo/semantics/acceptedVersion

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics

In collaboration with Compliant to Partaking